Introducing the general management of glomerular disease from a pediatric perspective based on the updated KDIGO guidelines

키워드

참고문헌 (39)

1. Kidney Disease : Improving Global Outcomes(KDIGO)Glomerular Diseases Work Group, "KDIGO 2021 clinical practice guideline for the management of glomerular diseases", Kidney Int, 100(4S), pp.S1~276 (2021)
2. Pettit C, "Kidney biopsy adequacy and complications in children: does technique matter?", Eur J Pediatr, 181, pp.2677~2684 (2022)
3. Ding JJ, "Risk factors for complications of percutaneous ultrasound-guided renal biopsy in children", Pediatr Nephrol, 35, pp.271~278 (2020)
4. 장경미, "Clinical Approach to Children with Proteinuria", Childhood Kidney Diseases, 21(2), pp.53~60 (2017), 대한소아신장학회
5. Antunes VV, "Diagnostic accuracy of the protein", creatinine ratio in urine samples to estimate 24-h proteinuria in patients with primary glomerulopathies : a longitudinal study, 2008, pp.23, 2242~2246
6. Leung AK, "Proteinuria in children : evaluation and differential diagnosis", Am Fam Physician, 95, pp.248~254 (2017)
7. Pierce CB, "Ageand sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease", Kidney Int, 99, pp.948~956 (2021)
8. Hoste L, "A new equation to estimate the glomerular filtration rate in children, adolescents and young adults", Nephrol Dial Transplant, 29, pp.1082~1091 (2014)
9. Pottel H, "An estimated glomerular filtration rate equation for the full age spectrum", Nephrol Dial Transplant, 31, pp.798~806 (2016)
10. Kohler H, "Acanthocyturia : a characteristic marker for glomerular bleeding", Kidney Int, 40, pp.115~120 (1991)
11. Hamadah AM, "Urinalysis for the diagnosis of glomerulonephritis : role of dysmorphic red blood cells", Nephrol Dial Transplant, 33, pp.1397~1403 (2018)
12. Kaku Y, "Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013 : general therapy", Clin Exp Nephrol, 19, pp.34~53 (2015)
13. Gupta S, "Nephrotic syndrome : oedema formation and its treatment with diuretics", Front Physiol, 9, pp.1868~ (2019)
14. Bockenhauer D, "Over-or underfill : not all nephrotic states are created equal", Pediatr Nephrol, 28, pp.1153~1156 (2013)
15. Polderman N, "Dietary intakes of children with nephrotic syndrome", Pediatr Nephrol, 36, pp.2819~2826 (2021)
16. Momoniat T, "ACE inhibitors and ARBs : managing potassium and renal function", Cleve Clin J Med, 86, pp.601~607 (2019)
17. Toblli JE, "Understanding the mechanisms of proteinuria : therapeutic implications", Int J Nephrol, 2012, pp.546039~ (2012)
18. Schmidt M, "Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks : cohort study", BMJ, 356, pp.j791~ (2017)
19. Stotter BR, "Should ACE inhibitors and ARBs be used in combination in children?", Pediatr Nephrol, 34, pp.1521~1532 (2019)
20. Bomback AS, "Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD : a systematic review", Am J Kidney Dis, 51, pp.199~211 (2008)
21. Zhang Z, "The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: a meta-analysis", Pharmacol Res, 105, pp.74~83 (2016)
22. Chapter 4, "Pharmacological cholesterol-lowering treatment in children", Kidney Int Suppl(2011), 3, pp.282~283 (2013)
23. Sunil B, "Novel therapeutic targets and agents for pediatric dyslipidemia", Ther Adv Endocrinol Metab, 12, pp.204201882110583~ (2021)
24. Phan BA, "Ezetimibe therapy : mechanism of action and clinical update", Vasc Health Risk Manag, 8, pp.415~427 (2012)
25. Katzmann JL, "PCSK9 inhibition : insights from clinical trials and future prospects", Front Physiol, 11, pp.595819~ (2020)
26. Lin R, "A systematic review of prophylactic anticoagulation in nephrotic syndrome", Kidney Int Rep, 5, pp.435~447 (2019)
27. Kerlin BA, "Venous thromboembolism in pediatric nephrotic syndrome", Pediatr Nephrol, 29, pp.989~997 (2014)
28. Andolino TP, "Nephrotic syndrome", Pediatr Rev, 36, pp.117~126 (2015)
29. 박세진, "Complications of nephrotic syndrome", Clinical and Experimental Pediatrics, 54(8), pp.322~328 (2011), 대한소아청소년과학회
30. Leonard MB, "Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome", N Engl J Med, 351, pp.868~875 (2004)
31. Mauras N, "Growth hormone therapy in the glucocorticosteroid-dependent child : metabolic and linear growth effects", Horm Res, (56 Suppl 1), pp.13~18 (2001)
32. Sampathkumar K, "Acute interstitial nephritis due to proton pump inhibitors", Indian J Nephrol, 23, pp.304~307 (2013)
33. Li Y, "Proton pump inhibitors and the risk of hospital-acquired acute kidney injury in children", Ann Transl Med, 8, pp.1438~ (2020)
34. Ueda N, "Eight and 12 week courses of cyclophosphamide in nephrotic syndrome", Arch Dis Child, 65, pp.1147~1150 (1990)
35. Sinha A, "Rituximab therapy in nephrotic syndrome : implications for patients’ management", Nat Rev Nephrol, 9, pp.154~169 (2013)
36. Labrosse R, "Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients", J Allergy Clin Immunol, 148, pp.523~532 (2021)
37. Uauy RD, "Dietary protein and growth in infants with chronic renal insufficiency:a report from the Southwest Pediatric Nephrology Study Group and the University of California, San Francisco", Pediatr Nephrol, 8, pp.45~50 (1994)
38. Wingen AM, "Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children", Lancet, 349, pp.1117~1123 (1997), European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood
39. Shaw V, "Energy and protein requirements for children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce", Pediatr Nephrol, 35, pp.519~531 (2020)

관련 논문AI추천